As of 2025-11-09, the Relative Valuation of TCR2 Therapeutics Inc (TCRR) is (64.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.48 USD, the upside of TCR2 Therapeutics Inc based on Relative Valuation is -4457.6%.
The range of the Relative Valuation is (64.22) - (64.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 15.6x | 15.6x |
| Forward P/E multiples | 15.4x - 15.6x | 15.5x |
| Fair Price | (64.22) - (64.89) | (64.49) |
| Upside | -4439.4% - -4484.3% | -4457.6% |
| Date | P/E |